Dan Leonard
Stock Analyst at UBS
(3.11)
# 1,267
Out of 4,761 analysts
278
Total ratings
54.61%
Success rate
8.53%
Average return
Main Sectors:
Stocks Rated by Dan Leonard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TXG 10x Genomics | Maintains: Neutral | $20 → $14 | $10.90 | +28.44% | 4 | Feb 13, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $260 → $255 | $191.04 | +33.48% | 13 | Feb 7, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $700 → $715 | $532.55 | +34.26% | 14 | Jan 31, 2025 | |
| AVTR Avantor | Downgrades: Neutral | $29 → $25 | $17.30 | +44.51% | 7 | Jan 17, 2025 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | $250 → $185 | $163.02 | +13.48% | 6 | Jan 17, 2025 | |
| BRKR Bruker | Assumes: Neutral | $102 → $66 | $50.82 | +29.87% | 10 | Dec 10, 2024 | |
| DHR Danaher | Maintains: Buy | $309 → $305 | $210.23 | +45.08% | 16 | Oct 23, 2024 | |
| CYRX Cryoport | Maintains: Neutral | $7 → $9 | $6.22 | +44.69% | 2 | Oct 18, 2024 | |
| MEDP Medpace Holdings | Downgrades: Neutral | $420 → $350 | $340.22 | +2.87% | 1 | Sep 27, 2024 | |
| CERT Certara | Upgrades: Buy | $16 | $13.17 | +21.49% | 9 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $40 | $42.87 | -6.69% | 8 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $420 → $385 | $312.05 | +23.38% | 19 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $420 → $385 | $280.08 | +37.46% | 19 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $105 → $125 | $113.84 | +9.80% | 1 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $64.92 | +23.23% | 10 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $16.46 | +112.64% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $160 → $150 | $135.37 | +10.81% | 21 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $200 | $94.20 | +112.31% | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $11 | $4.11 | +167.64% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $70 | $162.31 | -56.87% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $90 | $49.26 | +82.70% | 9 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | $7 | $8.27 | -15.36% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $345 | $374.82 | -7.96% | 12 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $260 | $201.39 | +29.10% | 5 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $160 → $145 | $172.24 | -15.82% | 10 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $90 | $64.49 | +39.56% | 12 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $62 → $64 | $39.57 | +60.85% | 3 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $330 → $340 | $249.85 | +36.08% | 11 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $20.90 | +14.83% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $1,350 → $1,500 | $1,286.54 | +16.59% | 8 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $45 → $35 | $14.18 | +146.83% | 12 | Aug 14, 2019 |
10x Genomics
Feb 13, 2025
Maintains: Neutral
Price Target: $20 → $14
Current: $10.90
Upside: +28.44%
IQVIA Holdings
Feb 7, 2025
Maintains: Buy
Price Target: $260 → $255
Current: $191.04
Upside: +33.48%
Thermo Fisher Scientific
Jan 31, 2025
Maintains: Buy
Price Target: $700 → $715
Current: $532.55
Upside: +34.26%
Avantor
Jan 17, 2025
Downgrades: Neutral
Price Target: $29 → $25
Current: $17.30
Upside: +44.51%
Charles River Laboratories International
Jan 17, 2025
Downgrades: Neutral
Price Target: $250 → $185
Current: $163.02
Upside: +13.48%
Bruker
Dec 10, 2024
Assumes: Neutral
Price Target: $102 → $66
Current: $50.82
Upside: +29.87%
Danaher
Oct 23, 2024
Maintains: Buy
Price Target: $309 → $305
Current: $210.23
Upside: +45.08%
Cryoport
Oct 18, 2024
Maintains: Neutral
Price Target: $7 → $9
Current: $6.22
Upside: +44.69%
Medpace Holdings
Sep 27, 2024
Downgrades: Neutral
Price Target: $420 → $350
Current: $340.22
Upside: +2.87%
Certara
Sep 27, 2024
Upgrades: Buy
Price Target: $16
Current: $13.17
Upside: +21.49%
Aug 21, 2024
Maintains: Buy
Price Target: $32 → $40
Current: $42.87
Upside: -6.69%
May 8, 2024
Maintains: Buy
Price Target: $420 → $385
Current: $312.05
Upside: +23.38%
May 8, 2024
Maintains: Buy
Price Target: $420 → $385
Current: $280.08
Upside: +37.46%
Jan 16, 2024
Downgrades: Neutral
Price Target: $105 → $125
Current: $113.84
Upside: +9.80%
Dec 7, 2023
Initiates: Buy
Price Target: $80
Current: $64.92
Upside: +23.23%
Dec 7, 2023
Initiates: Neutral
Price Target: $35
Current: $16.46
Upside: +112.64%
Aug 16, 2023
Maintains: Outperform
Price Target: $160 → $150
Current: $135.37
Upside: +10.81%
Aug 10, 2023
Maintains: Neutral
Price Target: $225 → $200
Current: $94.20
Upside: +112.31%
Aug 8, 2023
Maintains: Neutral
Price Target: $14 → $11
Current: $4.11
Upside: +167.64%
Aug 4, 2023
Reiterates: Outperform
Price Target: $70
Current: $162.31
Upside: -56.87%
Aug 2, 2023
Maintains: Neutral
Price Target: $75 → $90
Current: $49.26
Upside: +82.70%
Feb 15, 2023
Reiterates: Underperform
Price Target: $7
Current: $8.27
Upside: -15.36%
Aug 25, 2022
Initiates: Neutral
Price Target: $345
Current: $374.82
Upside: -7.96%
Aug 25, 2022
Initiates: Neutral
Price Target: $260
Current: $201.39
Upside: +29.10%
Feb 4, 2022
Maintains: Equal-Weight
Price Target: $160 → $145
Current: $172.24
Upside: -15.82%
Feb 3, 2022
Maintains: Overweight
Price Target: $95 → $90
Current: $64.49
Upside: +39.56%
Dec 14, 2021
Maintains: Equal-Weight
Price Target: $62 → $64
Current: $39.57
Upside: +60.85%
Dec 14, 2021
Maintains: Overweight
Price Target: $330 → $340
Current: $249.85
Upside: +36.08%
Aug 10, 2021
Initiates: Overweight
Price Target: $24
Current: $20.90
Upside: +14.83%
Jul 30, 2021
Maintains: Equal-Weight
Price Target: $1,350 → $1,500
Current: $1,286.54
Upside: +16.59%
Aug 14, 2019
Maintains: Hold
Price Target: $45 → $35
Current: $14.18
Upside: +146.83%